Pharmacy Benefit Managers: Driving Up Cost of Care with No Accountability
In last week’s Senate Finance Committee hearing on drug pricing, U.S. Secretary of Health and Human Services Alex Azar reiterated the Trump...
In last week’s Senate Finance Committee hearing on drug pricing, U.S. Secretary of Health and Human Services Alex Azar reiterated the Trump...
GERARD SCIMECA – CHAIRMAN, CASE June 29, 2018 – https://bit.ly/2KHS7LK The words “Made in China” now hang in the balance on...
GERARD SCIMECA – CHAIRMAN, CASE April 27, 2018 – https://bit.ly/2HUY75B Americans have long likened politicians to used car salesman, without it...
GERARD SCIMECA – CHAIRMAN, CASE April 25, 2018 – https://bit.ly/2qZ2ORn President Trump has admirably prioritized America’s energy assets, declaring his administration’s goal of...
Tax Reform Passage a Tremendous Win for America’s Workers & Consumers (Arlington, Virginia) — Today CASE – Consumer Action for a...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/